Differential Pharmacokinetics of Ganitumab in Patients With Metastatic Pancreatic Cancer Versus Other Advanced Solid Cancers

Publisher： John Wiley & Sons Inc

E-ISSN： 2160-7648|2|4|367-378

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.2, Iss.4, 2013-10, pp. : 367-378

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Meta-Analysis of Randomised Trials Comparing Gemcitabine-Based Doublets versus Gemcitabine Alone in Patients with Advanced and Metastatic Pancreatic Cancer

By Banu Eugeniu

Drugs & Aging, Vol. 24, Iss. 10, 2007-01 ,pp. : 865-879

Adis International

Access to resources Recommend Favorite

Docetaxel is active in patients with unresectable metastatic or locally advanced pancreatic cancer

Inpharma, Vol. 1, Iss. 1248, 2000-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer: a prospective observational study

By Karasek Petr Skacel Tomas Kocakova Ilona Bednarik Otakar Petruzelka Lubos Melichar Bohuslav Bustova Ivana Spurny Vladimir Trason Tomas

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 4, 2003-04 ,pp. : 581-586

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Metastatic Pancreatic Cancer

By Ko Andrew H. Tempero Margaret A.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 3, Iss. 5, 2005-09 ,pp. : 627-636

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Paclitaxel: An Update of its Use in the Treatment of Metastatic Breast Cancer and Ovarian and Other Gynaecological Cancers

By Wiseman L.R. Spencer C.M.

Drugs & Aging, Vol. 12, Iss. 4, 1998-04 ,pp. : 305-334

Adis International

Access to resources Recommend Favorite